The OCT SORT-OUT VIII Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

December 31, 2025

Conditions
Coronary Artery DiseaseAngina PectorisMyocardial Infarction
Interventions
DEVICE

Everolimus eluting bioresorbable polymer stent

DEVICE

Biolimus eluting bioresorbable polymer stent

Trial Locations (2)

5000

Odense University Hospital, Odense

8200

Aarhus University Hospital, Skejby, Aarhus

All Listed Sponsors
collaborator

Biosensors International

OTHER

collaborator

Boston Scientific Corporation

INDUSTRY

lead

Aarhus University Hospital Skejby

OTHER